| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 35.66B | 33.53B | 36.84B | 33.45B | 30.51B |
| Gross Profit | 11.07B | 10.82B | 9.93B | 10.96B | 10.28B | 9.10B |
| EBITDA | 6.93B | 6.76B | 6.31B | 6.60B | 6.09B | 5.09B |
| Net Income | 4.08B | 3.87B | 3.33B | 4.08B | 3.47B | 2.76B |
Balance Sheet | ||||||
| Total Assets | 59.05B | 59.80B | 59.45B | 56.67B | 54.81B | 53.27B |
| Cash, Cash Equivalents and Short-Term Investments | 12.45B | 14.30B | 12.86B | 8.94B | 12.86B | 14.37B |
| Total Debt | 17.21M | 1.10B | 27.65M | 35.66M | 16.32M | 15.01M |
| Total Liabilities | 9.80B | 10.73B | 11.89B | 10.57B | 10.25B | 10.42B |
| Stockholders Equity | 48.35B | 48.16B | 46.65B | 45.27B | 43.73B | 42.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.75B | 5.01B | -1.32B | -542.08M | 1.96B |
| Operating Cash Flow | 0.00 | 4.09B | 6.28B | 1.44B | 2.29B | 4.70B |
| Investing Cash Flow | 0.00 | -1.77B | -634.16M | -1.78B | -2.74B | -2.42B |
| Financing Cash Flow | 0.00 | -602.16M | -2.55B | -3.32B | -1.40B | -874.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥89.94B | 12.06 | 10.57% | 1.74% | 15.12% | 40.72% | |
75 Outperform | ¥58.20B | 12.82 | ― | 2.92% | 3.03% | 28.27% | |
72 Outperform | ¥66.64B | 21.52 | 6.31% | 4.01% | 6.38% | 22.81% | |
69 Neutral | ¥50.80B | 8.80 | 10.88% | 4.46% | -1.14% | 34.15% | |
67 Neutral | ¥56.84B | 12.62 | ― | 2.81% | 8.28% | 0.70% | |
64 Neutral | ¥74.16B | 38.61 | ― | 1.60% | 1.20% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Nippon Fine Chemical reported consolidated net sales of ¥24.88 billion for the nine months ended December 31, 2025, down 6.5% year on year, but improved profitability, with operating profit up 2.6% to ¥3.85 billion and profit attributable to owners of parent jumping 23.1% to ¥3.45 billion, supported by higher basic earnings per share of ¥157.37 and a rise in comprehensive income. The company maintained a strong financial position with total assets of ¥63.87 billion and an equity-to-asset ratio of 77.8%, and it affirmed its full-year forecast for FY2025/26, projecting only a slight 1.9% decline in net sales to ¥35.0 billion but double-digit growth in operating and ordinary profit and a 16.3% rise in net profit, while also planning to raise annual dividends to ¥94 per share, signaling continued shareholder returns despite a modest top-line slowdown.
The most recent analyst rating on (JP:4362) stock is a Buy with a Yen3386.00 price target. To see the full list of analyst forecasts on Nippon Fine Chemical Co., Ltd. stock, see the JP:4362 Stock Forecast page.
Nippon Fine Chemical Co., Ltd. announced the retirement of 1,550,000 common shares, representing 6.1% of issued shares, as part of a strategic move to optimize its capital structure. This decision, effective November 20, 2025, is expected to enhance shareholder value and reflects the company’s proactive approach to managing its financial resources.
The most recent analyst rating on (JP:4362) stock is a Hold with a Yen2764.00 price target. To see the full list of analyst forecasts on Nippon Fine Chemical Co., Ltd. stock, see the JP:4362 Stock Forecast page.
Nippon Fine Chemical Co., Ltd. has revised its earnings forecast for the fiscal year ending March 2026, citing better-than-expected results in the second quarter. The company anticipates increases in net sales, operating profit, and profit attributable to owners, reflecting strong performance in its beauty care, healthcare, and fine chemicals segments.
The most recent analyst rating on (JP:4362) stock is a Hold with a Yen2764.00 price target. To see the full list of analyst forecasts on Nippon Fine Chemical Co., Ltd. stock, see the JP:4362 Stock Forecast page.
Nippon Fine Chemical Co., Ltd. reported a modest increase in net sales for the first half of 2025, with significant growth in operating and ordinary profits, reflecting improved operational efficiency. The company has revised its earnings forecast for the fiscal year ending March 31, 2026, indicating a positive outlook despite a slight decrease in expected net sales, which suggests a strategic focus on profitability and shareholder value.
The most recent analyst rating on (JP:4362) stock is a Hold with a Yen2764.00 price target. To see the full list of analyst forecasts on Nippon Fine Chemical Co., Ltd. stock, see the JP:4362 Stock Forecast page.